Interleukin‐10 expression and function in experimental murine liver inflammation and fibrosis

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Hepatology

• Publication date

  1998-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.510280620PMID 9828224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology.

  2008cited by this paper
• Facilins, a novel class of biological factors that facilitate the aortic response to dopamine and other biogenic amines

  2005cited by this paper
• Expression of Interleukin-10 by in Vitro and in Vivo Activated Hepatic Stellate Cells*

  1998cited by this paper
• Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection.

  1997cited by this paper
• Age-related enhancement of 5-lipoxygenase metabolic capacity in cattle alveolar macrophages.

  1996cited by this paper
• Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase.

  1996cited by this paper
• Angiotensin II stimulates T-type Ca2+ channel currents via activation of a G protein, Gi.

  1996cited by this paper
• Interleukin‐10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts

  1995cited by this paper
• Interferon-gamma and interleukin-10 messenger RNA are up-regulated after orthotopic liver transplantation in tolerant rats: evidence for cytokine-mediated immune dysregulation.

  1995cited by this paper
• IL-10 blocks collagen IV invasion by "invasion stimulating factor" activated PC-3 ML cells: upregulation of TIMP-1 expression.

  1995cited by this paper
• IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes.

  1995cited by this paper
• IL‐10 up‐regulates human monocyte phagocytosis in the presence of IL‐4 and IFN‐γ

  1995cited by this paper
• Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses

  1995cited by this paper
• IL-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultured human blood monocytes: effects of IL-10 and other cytokines on cell phenotype and phagocytosis.

  1995cited by this paper
• Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms.

  1995cited by this paper
• Cytokine (IL-10, IL-6) induction of tissue inhibitor of metalloproteinase 1 in primary human prostate tumor cell lines.

  1995cited by this paper
• Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes

  1995cited by this paper
• Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge.

  1995cited by this paper
• Tissue distribution of IL-10 mRNA in normal mice. Evidence that a component of IL-10 expression is T and B cell-independent and increased by irradiation.

  1994cited by this paper
• Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopolysaccharide. Transcriptional and post-transcriptional regulation.

  1994cited by this paper
• Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production.

  1994cited by this paper
• Interleukin-10 inhibits interleukin-8 production in human neutrophils.

  1994cited by this paper
• Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes

  1994cited by this paper
• Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis.

  1994cited by this paper
• Regulation of neutrophil-derived chemokine expression by IL-10.

  1994cited by this paper
• Lipopolysaccharide-dependent induction of IL-10 receptor expression on murine fibroblasts.

  1994cited by this paper
• IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes.

  1994cited by this paper
• Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts.

  1994cited by this paper
• Interleukin-10.

  1993cited by this paper
• Cytokine messenger RNA profiles in hamster-to-rat liver xenografts.

  1993cited by this paper
• Cytokine mRNA expression in livers of mice infected with Listeria monocytogenes

  1993cited by this paper
• Interleukin‐4 and interleukin‐10 inhibit nitric oxide‐dependent macrophage killing of Candida albicans

  1993cited by this paper
• Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcription and semiquantitative polymerase chain reaction amplification.

  1993cited by this paper
• Kupffer Cells: Their Activation and Role in Animal Models of Liver Injury and Human Liver Disease

  1993cited by this paper
• IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.

  1992cited by this paper
• Regulation of human alveolar macrophage- and blood monocyte-derived interleukin-8 by prostaglandin E2 and dexamethasone.

  1992cited by this paper
• Epstein-Barr virus BCRF1 gene product (viral interleukin 10) inhibits superoxide anion production by human monocytes.

  1992cited by this paper
• Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10.

  1992cited by this paper
• IL-10 inhibits cytokine production by activated macrophages.

  1991cited by this paper
• Macrophage deactivation by interleukin 10

  1991cited by this paper
• Effects of TNFα on the Expression of Class II MHC Molecules in Macrophages Induced by IFNγ: Evidence for Suppression at the Level of Transcription

  1991cited by this paper
• Murine granulated metrial gland cells at uterine implantation sites are natural killer lineage cells.

  1991cited by this paper
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

  1991cited by this paper
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

  1991cited by this paper
• Effects of TNF alpha on the expression of class II MHC molecules in macrophages induced by IFN gamma: evidence for suppression at the level of transcription.

  1991cited by this paper
• Nonparenchymal Cells and Hepatotoxicity

  1990cited by this paper
• lnterleukin-10-Deficient Mice Develop Chronic Enterocolitis

  year unknowncited by this paper

• Glucosamine alleviates liver fibrosis through modulation of sinusoidal blood flow and hepatic immune responses.

  2025cites this paper
• Ziziphus hamur Engl., a Rare Medicinal Plant Modulates Cytokine and Hematological Levels during Sub-Acute Toxicity Studies in Wistar Rats

  2025cites this paper
• A three-year review (2023-2025) on the effectiveness of natural products from plants in treating major types of fibrosis.

  2025cites this paper
• Impact of microplastics exposure on liver health: A comprehensive meta-analysis.

  2024cites this paper
• Discovery of Bis-imidazolecarboxamide Derivatives as Novel, Potent, and Selective TNIK Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis.

  2024cites this paper
• Gut Microbial Impact on Colitis and Colitis-Associated Carcinogenesis in a Primary Sclerosing Cholangitis-IBD Model

  2024cites this paper
• Correlation of IL-10 and IL18 with the development of liver cirrhosis associated with hepatitis B virus infection: A systematic review.

  2024cites this paper
• Single-cell RNA-seq Revealed that Altered Tumor Infiltrating Lymphocytes in Cirrhotic Liver Indicate Development of Hepatocellular Carcinoma

  2023cites this paper
• Ameliorative effects of allogeneic and xenogenic bone marrow-derived mesechymal stem cells on carbon tetrachloride-induced rat liver injury and cirrhosis via modulation of oxidative stress, apoptosis, inflammation, and Nrf2 expression.

  2023cites this paper
• TGFβ1 priming enhances CXCR3‐mediated mesenchymal stromal cell engraftment to the liver and enhances anti‐inflammatory efficacy

  2023cites this paper
• The multifaceted role of macrophages during acute liver injury

  2023cites this paper
• Oral formulation of Wnt inhibitor complex reduces inflammation and fibrosis in intraperitoneal implants in vivo

  2023cites this paper
• Macrophage in liver Fibrosis: Identities and mechanisms.

  2023cites this paper
• The Effects of Probiotic Bacillus Spores on Dexamethasone-Treated Rats

  2023cites this paper
• Differential immunological effects of silica nanoparticles on peripheral blood mononuclear cells of silicosis patients and controls

  2022cites this paper
• Preliminary In Vivo Evidence of Oral Selenium Supplementation as a Potentiating Agent on a Vector-Based COVID-19 Vaccine in BALB/c Mice

  2022cites this paper
• Role of RIGI, MDA5 and interferon alpha of duck in Duck Plague infection – a novel report

  2022cites this paper
• Liver Regeneration: Changes in Oxidative Stress, Immune System, Cytokines, and Epigenetic Modifications Associated with Aging

  2022cites this paper
• A Comparison of XGBoost, Random Forest, and Nomograph for the Prediction of Disease Severity in Patients With COVID-19 Pneumonia: Implications of Cytokine and Immune Cell Profile

  2022cites this paper
• Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis

  2022cites this paper
• Role of CD4+ T-cells in the pathology of non-alcoholic fatty liver disease and related diseases

  2021cites this paper
• Hepatic stellate cells – from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology

  2021cites this paper
• Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis

  2021cites this paper
• Hydrogen-rich water protects liver injury in nonalcoholic steatohepatitis though HO-1 enhancement via IL-10 and Sirt 1 signaling.

  2021cites this paper
• Cirrhosis-associated immune dysfunction

  2021cites this paper
• Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis

  2021cites this paper
• Intestinal Barrier and Permeability in Health, Obesity and NAFLD

  2021cites this paper
• Emodin Attenuates Acetaminophen-Induced Hepatotoxicity via the cGAS-STING Pathway

  2021cites this paper
• The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis

  2020cites this paper
• CD14+ monocytes and CD163+ macrophages correlate with the severity of liver fibrosis in patients with chronic hepatitis C

  2020cites this paper
• The molecular mechanism underlining the preventive effect of vitamin D against hepatic and renal acute toxicity through the NrF2/BACH1/HO-1 pathway.

  2020cites this paper
• The anti-inflammatory, anti-oxidant and protective effects of probiotic mixture on organ toxicity in a rat model.

  2020cites this paper
• Genetic variation in IL-10 influences the progression of hepatitis B infection.

  2020cites this paper
• Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer‐Binding Protein C/EBP Transcription Factors

  2020influential citation
• Intrahepatic interleukin 10 expression modulates fibrinogenesis during chronic HCV infection

  2020cites this paper
• Immunopathogenesis of Liver Cirrhosis

  2020cites this paper
• Key Players of Hepatic Fibrosis

  2020cites this paper
• Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk

  2020cites this paper
• Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation

  2019cites this paper
• EPA plus DHA improves survival related to a decrease of injury after extended liver ischemia in Sprague-Dawley rats.

  2019cites this paper
• Role of macrophages in experimental liver injury and repair in mice.

  2019cites this paper
• Pericytes in the Liver.

  2019cites this paper
• Erythropoietin improves hepatic fibrosis via suppression of hepatic stellate cells and macrophage activation

  2019cites this paper
• Human Amnion Epithelial Cell Therapy for Chronic Liver Disease

  2019cites this paper
• Epidemiology and molecular biology of elephant endotheliotropic herpesvirus 1 in the Asian elephant Elephas maximus

  2018cites this paper
• Cytokine storms are primarily responsible for the rapid death of ducklings infected with duck hepatitis A virus type 1

  2018cites this paper
• Kyungheechunggan-tang suppresses inflammatory cytokines and fibrotic genes in LPS-induced RAW 264.7 cells and LX-2 cells

  2018cites this paper
• Differences in Genetic Background Contribute to Pseudomonas Exotoxin A-Induced Hepatotoxicity in Rats

  2017cites this paper
• Effect of ginseng extract on the TGF-β1 signaling pathway in CCl4-induced liver fibrosis in rats

  2017cites this paper
• Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice

  2017cites this paper
• An evaluation of the protective role of vitamin C in reactive oxygen species-induced hepatotoxicity due to hexavalent chromium in vitro and in vivo

  2017cites this paper
• Salvage Therapies for Autoimmune Hepatitis: A Critical Review

  2017cites this paper
• The Promising Role of Anti-Fibrotic Agent Halofuginone in Liver Fibrosis/Cirrhosis

  2017cites this paper
• Synthetic Amorphous Silica in Food : Findings about “ Liver Fibrosis ” and Other Study-Related Findings in Van der Zande

  2017cites this paper
• Liver and blood cytokine microenvironment in HCV patients is associated to liver fibrosis score: a proinflammatory cytokine ensemble orchestrated by TNF and tuned by IL-10

  2016cites this paper
• Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes

  2016cites this paper
• IRF 5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans

  2016cites this paper
• Presentation of hepatocellular antigens

  2016cites this paper
• Characterization of chemical-induced sterile inflammation in vitro: application of the model compound ketoconazole in a human hepatic co-culture system

  2016cites this paper
• Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis

  2016cites this paper
• Inflammation, oxidative stress and apoptosis cascade implications in bisphenol A‐induced liver fibrosis in male rats

  2016cites this paper
• IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans.

  2016cites this paper
• Neonatal exposure to ethinylestradiol increases ventral prostate growth and promotes epithelial hyperplasia and inflammation in adult male gerbils

  2016cites this paper
• Protective effects of Centella asiatica leaf extract on dimethylnitrosamine-induced liver injury in rats

  2016cites this paper
• β-1,3-グルカンを用いた薬物送達システムへの応用

  2015cites this paper
• Release of insulin from PLGA-alginate dressing stimulates regenerative healing of burn wounds in rats.

  2015cites this paper
• Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?

  2015cites this paper
• Hepatic fibrosis and cirrhosis

  2015cites this paper
• Changing outcomes with antiviral or antifibrotic therapies

  2015cites this paper
• Reversal of Cirrhosis

  2015cites this paper
• Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family

  2015cites this paper
• Restoring homeostasis of CD4⁺ T cells in hepatitis-B-virus-related liver fibrosis.

  2015cites this paper
• Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons

  2015cites this paper
• EVALUATION OF ANTIFIBROTIC AND ANTIOXIDANT EFFECTS OF OLMESARTAN MEDOXOMIL, A NEW ANGIOTENSIN II BLOCKER, ON EXPERIMENTALLY- INDUCED LIVER FIBROSIS IN RATS

  2014cites this paper
• Role of interleukins in renal, cardiac and liver diseases: an update

  2014cites this paper
• The novel Janus kinase inhibitor ruxolitinib confers protection against carbon tetrachloride-induced hepatotoxicity via multiple mechanisms.

  2014cites this paper
• Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis

  2014cites this paper
• interleukins in chronic liver disease: lessons learned from experimental mouse models

  2014cites this paper
• Protective Effect of Melatonin on Kainic Acid Induced-Liver Damage and Immune Modulatory Cytokines

  2014cites this paper
• Interleukins in chronic liver disease: lessons learned from experimental mouse models

  2014cites this paper
• Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model

  2013cites this paper
• with Hepatocyte Secretion of IL-10 Enhanced Oral Tolerance in Transgenic Mice

  2013cites this paper
• Carbon tetrachloride-induced hepatic injury through formation of oxidized diacylglycerol and activation of the PKC/NF-κB pathway

  2013cites this paper
• Interleukin-10 gene modification attenuates hepatocyte activation of rat hepatic stellate cells in vitro.

  2013cites this paper
• Pretreatment with lipopolysaccharide ameliorates Pseudomonas exotoxin A-induced hepatotoxicity in rats

  2013cites this paper
• The Protective Effect of Glycyrrhetinic Acid on Carbon Tetrachloride-Induced Chronic Liver Fibrosis in Mice via Upregulation of Nrf2

  2013cites this paper
• Neospora caninum: Activity of cholinesterases during the acute and chronic phases of an experimental infection in gerbils.

  2013cites this paper
• Cytokine mediated tissue fibrosis.

  2013cites this paper
• Redirecting interlukin-10 in the fibrotic liver : effects on the pathogenesis

  2013cites this paper
• Redirecting interlukin-10 in the fibrotic liver

  2013cites this paper
• In vitro processing of human bone marrow derived mesenchymal stem cells to enhance delivery in liver disease

  2013cites this paper
• Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice.

  2013cites this paper
• Graptopetalum Paraguayense Ameliorates Chemical-Induced Rat Hepatic Fibrosis In Vivo and Inactivates Stellate Cells and Kupffer Cells In Vitro

  2013cites this paper
• High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.

  2013cites this paper
• Modification of Interleukin-10 with Mannose-6-Phosphate Groups Yields a Liver-Specific Cytokine with Antifibrotic Activity in Rats

  2012cites this paper
• matrix metalloproteinase activity

  2012cites this paper
• CD11b+ Gr1+ bone marrow cells ameliorate liver fibrosis by producing interleukin‐10 in mice

  2012cites this paper
• Mechanisms of Hepatocyte Detoxification

  2012cites this paper
• Regulatory Role of Interleukin-10 and Interferon- γ in Severe Hepatic Central and Peripheral Fibrosisin Humans Infected with Schistosoma japonicum 1

  2012cites this paper
• Chapter 5 – Hepatic Fibrosis and Cirrhosis

  2012cites this paper